These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26961683)

  • 1. CoINcIDE: A framework for discovery of patient subtypes across multiple datasets.
    Planey CR; Gevaert O
    Genome Med; 2016 Mar; 8(1):27. PubMed ID: 26961683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A framework for generalized subspace pattern mining in high-dimensional datasets.
    Curry EW
    BMC Bioinformatics; 2014 Nov; 15(1):355. PubMed ID: 25413436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. InterSIM: Simulation tool for multiple integrative 'omic datasets'.
    Chalise P; Raghavan R; Fridley BL
    Comput Methods Programs Biomed; 2016 May; 128():69-74. PubMed ID: 27040832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unified computational model for revealing and predicting subtle subtypes of cancers.
    Ren X; Wang Y; Wang J; Zhang XS
    BMC Bioinformatics; 2012 May; 13():70. PubMed ID: 22548981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation of immune gene signatures in solid tumors and prognostic implications.
    Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
    BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
    Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
    Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.
    Wu L; Liu Z; Xu J; Chen M; Fang H; Tong W; Xiao W
    Biomark Med; 2015; 9(11):1053-65. PubMed ID: 26501477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral clustering using Nyström approximation for the accurate identification of cancer molecular subtypes.
    Shi M; Xu G
    Sci Rep; 2017 Jul; 7(1):4896. PubMed ID: 28687729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
    Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
    PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On Predicting lung cancer subtypes using 'omic' data from tumor and tumor-adjacent histologically-normal tissue.
    Pineda AL; Ogoe HA; Balasubramanian JB; Rangel Escareño C; Visweswaran S; Herman JG; Gopalakrishnan V
    BMC Cancer; 2016 Mar; 16():184. PubMed ID: 26944944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusternomics: Integrative context-dependent clustering for heterogeneous datasets.
    Gabasova E; Reid J; Wernisch L
    PLoS Comput Biol; 2017 Oct; 13(10):e1005781. PubMed ID: 29036190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus framework for exploring microarray data using multiple clustering methods.
    Laderas T; McWeeney S
    OMICS; 2007; 11(1):116-28. PubMed ID: 17411399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification.
    Wu D; Wang D; Zhang MQ; Gu J
    BMC Genomics; 2015 Dec; 16():1022. PubMed ID: 26626453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Mapping of Multiple clUsteriNg ALgorithms (COMMUNAL): A Robust Method for Selection of Cluster Number, K.
    Sweeney TE; Chen AC; Gevaert O
    Sci Rep; 2015 Nov; 5():16971. PubMed ID: 26581809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis.
    Bismeijer T; Canisius S; Wessels LFA
    PLoS Comput Biol; 2018 Oct; 14(10):e1006520. PubMed ID: 30379847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive discovery of subsample gene expression components by information explanation: therapeutic implications in cancer.
    Pepke S; Ver Steeg G
    BMC Med Genomics; 2017 Mar; 10(1):12. PubMed ID: 28292312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets.
    Lemieux S; Sargeant T; Laperrière D; Ismail H; Boucher G; Rozendaal M; Lavallée VP; Ashton-Beaucage D; Wilhelm B; Hébert J; Hilton DJ; Mader S; Sauvageau G
    Nucleic Acids Res; 2017 Jul; 45(13):e122. PubMed ID: 28472340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome.
    Zhang Z; Chen D; Fenstermacher DA
    BMC Genomics; 2007 Sep; 8():331. PubMed ID: 17883867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway-based deep clustering for molecular subtyping of cancer.
    Mallavarapu T; Hao J; Kim Y; Oh JH; Kang M
    Methods; 2020 Feb; 173():24-31. PubMed ID: 31247294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.